Elsevier,

Great American Diseases
Their Effects on the course of North American History
2022, Pages 301-317

This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by describing the history of AIDS.
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing coverage of the clinical syndrome of a primary progressive aphasia (PPA), the demographics of this rare neurodegenerative disease, defining clinical and neuroanatomic characteristics of each PPA variant, disease progression, and behavioral features.
Elsevier,

Autophagy Dysfunction in Alzheimer's Disease and Dementia, First Edition, 2022, pp 73-89

This chapter advances the UN SDG goals 3 and 17 discusses the links of Amyloid β(Aβ) to AD.
Elsevier,

Autophagy Dysfunction in Alzheimer's Disease and Dementia, First Edition, 2022, pp 263-290

This chapter advances the UN SDG goals 3 and 17 by reviewing recent drug discoveries and autophagy regulation which is essential for the treatment of AD.
This chapter advances the UN SDG goals 3 and 17 by brings together medical and computational domains to discuss the use of deep learning (DL) and machine learning (ML) in the early detection of AD.
An Article in support of SDG 3, showing that universal HIV testing and treatment improved employment outcomes and other indicators of socioeconomic wellbeing for HIV-positive adults and children in their households, but had no effect on HIV-negative adults.
Background: WHO promotes the SAFE strategy for the elimination of trachoma as a public health programme, which promotes surgery for trichiasis (ie, the S component), antibiotics to clear the ocular st
Elsevier,

Clinical Ophthalmic Genetics and Genomics, 2022, Pages 457-463Gallie

Understanding the genetics of retinoblastoma has enabled clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk. The goal of SDG target 3.d is to strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risk.
Elsevier,


Clinical Ophthalmic Genetics and Genomics
2022, Pages 457-463

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing understaning of the genetics of retinoblastoma enabling clinicians to develop targeted screening guidelines based on genetic risk, minimising unnecessary screening exams, and focusing resources on individuals at greatest risk.

Pages